ARUP's Laboratory Test Directory

MUTYH-Associated Polyposis (MUTYH) 2 Mutations with Reflex to Sequencing : 2006307
[ image for: Patient History for MUTYH-Associated Polyposis Testing]
Patient History for MUTYH-Associated Polyposis Testing
[ image for: Additional Technical Information]
Additional Technical Information


Mnemonic: MUTYH RFLX

Methodology: Polymerase Chain Reaction/Sequencing
Performed: Varies
Reported: Within 28 days
Specimen Required: Collect: Lavender (EDTA), pink (K2EDTA), or yellow (ACD Solution A or B).

Specimen Preparation: Transport 3 mL whole blood. (Min: 1 mL)

Storage/Transport Temperature: Refrigerated.

Stability (collection to initiation of testing): Ambient: 72 hours; Refrigerated: 1 week; Frozen: Unacceptable

Interpretive Data: Background Information for MUTYH-Associated Polyposis (MUTYH) 2 Mutations with Reflex to Sequencing:
Characteristics of MUTYH-Associated Polyposis (MAP):
Development of colonic polyps (10-100) in the third decade or later.
Incidence:
Less than 1 percent of colorectal cancer cases.
Inheritance:
Autosomal recessive.
Penetrance:
Greater than 99 percent in untreated individuals.
Cause:
Pathogenic biallelic MUTYH gene mutations.
Clinical Sensitivity:
98 percent of MUTYH mutations.
Methodology:
Targeted testing for the MUTYH gene mutations c.494A>G (Y165C) and c.1145G>A (G382D) by PCR and bidirectional sequencing. If two mutations are not identified, bidirectional sequencing of the other MUTYH coding regions and intron-exon boundaries is performed.
Analytical Sensitivity and Specificity:
99 percent.
Limitations:
Rare diagnostic errors can occur due to primer site mutations. MUTYH regulatory region mutations, deep intronic mutations, and large deletion/duplications will not be detected.

Counseling and informed consent are recommended for genetic testing. Consent forms are available online at www.aruplab.com.

Refer to Statement C under Testing Information at <http://www.aruplab.com>.



Counseling and informed consent are recommended for genetic testing. Consent forms are available online at www.aruplab.com.

See Compliance Statement C: www.aruplab.com/CS
Note: Testing for the two targeted MUTYH mutations is performed on all samples. If results do not explain the clinical scenario, then sequencing of the other MUTYH coding regions and intron-exon boundaries is performed. Additional charges apply.
CPT Code(s): 81401; If reflexed add 81406
Cross References: MAP (MUTYH-Associated Polyposis) 2 Mutations with Reflex to Sequencing, MYH -Associated Polyposis 2 Mutations with Reflex to Sequencing